30S ribosomal subunit (30S) (30S subunit)

The 30S ribosomal subunit is the smaller component of the prokaryotic 70S ribosome, composed of the 16S ribosomal RNA (rRNA) and approximately 21 ribosomal proteins (NCBI, 2023). Its primary biological function is to initiate protein translation and ensure the fidelity of the decoding process by facilitating the correct pairing between mRNA codons and tRNA anticodons (UniProt, 2024). Because the 30S subunit is structurally distinct from the eukaryotic 40S subunit, it is a primary target for several classes of antibacterial agents, allowing for selective toxicity against pathogens (StatPearls, 2023). Antibiotics such as aminoglycosides and tetracyclines bind to specific sites within the 30S subunit to inhibit protein synthesis, either by blocking the entry of aminoacyl-tRNA or by causing the ribosome to misread the genetic code (PubMed, 2021). These drugs are vital for treating various systemic and localized bacterial infections, although their use is often complicated by the emergence of resistance mechanisms and potential side effects like renal or auditory damage (StatPearls, 2023).

Other names

Small ribosomal subunitProkaryotic small ribosomal subunit16S ribosomal subunitBacterial 30S subunit

Inhibition of bacterial protein synthesis by binding to the 16S rRNA or ribosomal proteins. Aminoglycosides induce mRNA misreading and inhibit translocation, while tetracyclines block the A-site to prevent aminoacyl-tRNA binding (StatPearls, 2023; PubMed, 2021).